Morgan Stanley sets $40 target on Kyverna Therapeutics shares By Investing.com
© Reuters. On Monday, Morgan Stanley initiated protection on Kyverna Therapeutics Inc (NASDAQ:KYTX), a biopharmaceutical firm, with an Chubby ranking ...
Tag: Kyverna